ABSTRACT

COVID-19 outbreak has emerged as most dangerous threat across the globe wrecking populations and economies since December 2019. It is a burning topic worldwide that has become a big challenge for the scientists and researchers to find a solution for this deadly disease. Although, there is plenty of literature supporting the effectiveness of herbs in treating viral infections but it is somewhat difficult to predict how well particular herbs perform as in most cases they are administered with allopathic medications. While scientists still struggle for claiming the efficacy, recommendation of unproved and clinically untested molecules by health authorities merely based on available data can be misleading and potentially dangerous. Well, a few preventive measures can be advised but not treatment advice until the potential drugs are screened for their pharmacological activity against COVID-19. This Review explores a certain group of phytochemicals- triterpenes from natural godowns and their possible efficacy against respiratory viral infections to serve as potential drugs for treatment of SARS-CoV-2 as we await the development and testing of specific anti-viral drugs. Keywords: Triterpenoids, COVID- 19, SARS- severe acute respiratory syndrome, potential leads
Publication date: 01/10/2025

https://ijbpas.com/pdf/2025/October/MS_IJBPAS_2025_9500.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2025/14.10.9500